Difference between revisions of "Chromogranin"
(New page: {{subst:infobox}}) |
m |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | |||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
Line 12: | Line 11: | ||
|- | |- | ||
| Determination type | | Determination type | ||
− | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
− | | | + | | Bos taurus |
|- | |- | ||
| Subcellular localization | | Subcellular localization | ||
− | | | + | | Secreted |
|- | |- | ||
| Swissprot ID | | Swissprot ID | ||
− | | [http://au.expasy.org/uniprot/ | + | | [http://au.expasy.org/uniprot/P05059 P05059 ] |
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
− | | | + | | Not determined yet |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
Line 30: | Line 29: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
− | | | + | | |
|- | |- | ||
| Structure | | Structure | ||
− | | [http://www. | + | | [http://www.pdb.org/pdb/cgi/explore.cgi?job=download&pdbId=1n2y&page=&pid=&opt=show&format=PDB&header=1&pre=1 1N2Y] |
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
− | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Line 42: | Line 41: | ||
|- | |- | ||
| Reference | | Reference | ||
− | | [http://www.ncbi.nlm.nih.gov/sites/entrez? | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=5132120&ordinalpos=608&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum PMID:5132120] |
|- | |- | ||
| Notes | | Notes |
Latest revision as of 06:15, 2 September 2007
Template:Infobox header| Chromogranin | |
---|---|
Chromogranin | |
Substrate peptide name | Chromogranin |
Synonyms | - |
Determination type | In vitro |
Source | Bos taurus |
Subcellular localization | Secreted |
Swissprot ID | P05059 |
Reactive glutamines | Not determined yet |
Reactive lysines | Not determined yet |
Substrate sequence | |
Structure | 1N2Y |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:5132120 |
Notes | |
Template:Infobox header | |